Log in
(Ad)
If you're happy with stocks yielding you 4% or 5% a year, you don't need this. But if you want to see how we built a portfolio that now pays us a 67% cash on cash return - with no leverage, options, or gimmicks.

NYSEAMERICAN:NNVC - NanoViricides Stock Price, Forecast & News

$3.36
+0.06 (+1.82 %)
(As of 01/19/2020 04:00 PM ET)
Today's Range
$3.31
Now: $3.36
$3.53
50-Day Range N/A
52-Week Range
$1.27
Now: $3.36
$13.60
Volume34,473 shs
Average Volume106,700 shs
Market Capitalization$12.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as injectable and oral anti-influenza nanoviricide drug for H7N9, Bird Flu H5N1, other Highly Pathogenic Influenzas, Epidemic Influenzas, and Seasonal Influenzas; DengueCide, an anti-dengue nanoviricide which is in pre-clinical development; and HIVCide, an anti-human immunodeficiency virus drug candidate. It is also developing HerpeCide, a skin cream for the treatment of cold sores and genital herpes virus infections; and eye drops against viral infections of the external eye, as well as involved in the other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:NNVC
Previous SymbolNYSEMKT:NNVC
CUSIPN/A
Phone+1-203-9376137

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees7
Market Cap$12.95 million
Next Earnings Date2/18/2020 (Estimated)
OptionableOptionable

Receive NNVC News and Ratings via Email

Sign-up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

NanoViricides (NYSEAMERICAN:NNVC) Frequently Asked Questions

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NNVC."

When did NanoViricides' stock split? How did NanoViricides' stock split work?

Shares of NanoViricides reverse split on Tuesday, September 24th 2019. The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of NanoViricides stock prior to the reverse split would have 5 shares after the split.

How were NanoViricides' earnings last quarter?

NanoViricides Inc (NYSEAMERICAN:NNVC) released its quarterly earnings results on Friday, November, 15th. The company reported ($0.41) earnings per share for the quarter. View NanoViricides' Earnings History.

When is NanoViricides' next earnings date?

NanoViricides is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for NanoViricides.

Has NanoViricides been receiving favorable news coverage?

Press coverage about NNVC stock has been trending positive this week, InfoTrie reports. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NanoViricides earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for NanoViricides.

Are investors shorting NanoViricides?

NanoViricides saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 192,300 shares, an increase of 27.8% from the December 15th total of 150,500 shares. Based on an average daily volume of 40,700 shares, the short-interest ratio is currently 4.7 days. Approximately 7.0% of the shares of the company are sold short. View NanoViricides' Current Options Chain.

Who are some of NanoViricides' key competitors?

What other stocks do shareholders of NanoViricides own?

Who are NanoViricides' key executives?

NanoViricides' management team includes the folowing people:
  • Dr. Anil R. Diwan, Chairman, Pres & Sec. (Age 60)
  • Ms. Meeta R. Vyas SB, MBA, Chief Financial Officer (Age 60)
  • Dr. Eugene Seymour, Chief Exec. Officer Emeritus (Age 78)
  • Dr. Randall W. Barton Ph.D., Chief Scientific Officer & Chief Regulatory Officer (Age 72)
  • Dr. Irach B. Taraporewala, Consultant & Director (Age 63)

How do I buy shares of NanoViricides?

Shares of NNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $3.36.

How big of a company is NanoViricides?

NanoViricides has a market capitalization of $12.95 million. NanoViricides employs 7 workers across the globe.View Additional Information About NanoViricides.

What is NanoViricides' official website?

The official website for NanoViricides is http://www.nanoviricides.com/.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Dr, SHELTON, CT 06484-6153, United States. The company can be reached via phone at +1-203-9376137.


MarketBeat Community Rating for NanoViricides (NYSEAMERICAN NNVC)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about NanoViricides and other stocks. Vote "Outperform" if you believe NNVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NNVC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel